Joshua Krieger
Skip to content
Explore Our Coronavirus Coverage

Joshua Krieger

U.S. Firms Are Investing Heavily in Innovation, Yet Economic Productivity Has Slowed. Why?

The answer may lie in how pharmaceutical companies are targeting their R&D spending.

Researchers: Efraim Benmelech, Janice C. Eberly, Joshua Krieger and Dimitris Papanikolaou

June 1, 2021

Economics

Everyone Wants Pharmaceutical Breakthroughs. What Drives Drug Companies to Pursue Them?

A new study suggests that firms are at their most innovative after a financial windfall.

Researchers: Joshua Krieger, Danielle Li and Dimitris Papanikolaou

September 6, 2018

Innovation